Business | |||||||
NEWS | |||||||
Hedge funds in 2022 post worst performance since 2018, dragged down by equities -HFR data While equity and crypto portfolio managers faced challenges last year, hedge fund investors found bright spots to get return. Macro hedge funds outperformed the industry, HFR showed. The HFRI Macro Index rose 9.31%, mainly driven by commodities, ...
| |||||||
Morgan Stanley COO Jon Pruzan to retire Jan 9 (Reuters) - Morgan Stanley Chief Operating Officer Jon Pruzan will retire from the bank at the end of the month, according to a memo seen by Reuters. Formerly the finance chief at the Wall Street titan, Pruzan was made COO as part of a leadership ...
| |||||||
Editas to cut jobs, narrow research focus in restructuring Editas Medicine will lay off a fifth of its workforce and substantially cut back its drug research in a restructuring meant to prioritize progress on a CRISPR-based medicine for sickle cell disease and beta thalassemia. Editas, which has faced clinical ...
| |||||||
Danone sued in French court over plastic use Danone was taken to court in France today (9 January) by three environmental groups over its use of plastic across the supply chain. NGOs ClientEarth, Surfrider Foundation Europe and Zero Waste France filed a lawsuit against the French company claiming ...
| |||||||
Former Apple Inc. Chief Privacy Officer Jane Horvath Joins Gibson Dunn's DC Office January 9, 2023. Gibson, Dunn & Crutcher LLP announced today that Apple Inc.'s Chief Privacy Officer, Jane Horvath, has joined the firm's Washington, D.C. office as a partner. Horvath will become Co-Chair of the Privacy, Cybersecurity and Data ...
| |||||||
LastPass users encouraged to change passwords stored in LastPass to protect accounts Unknown actors were able to obtain backup versions of user vaults (an individualized data store of websites, usernames, and passwords), which included both unencrypted and encrypted information. Until LastPass can provide information on which vaults were ...
| |||||||
Royalty Pharma agrees to buy Ionis Pharma royalties for $1.125 bln Royalty Pharma Plc said Monday it agreed to pay up to $1.125 billion for drug royalties owned by Ionis Pharmaceuticals Inc. . The royalties include Ionis' interests in Biogen's Spinraza (nusinersen) medicine and Novartis' pelacarsen.
| |||||||
Short-Term Inflation Expectations Continue to Decline, Tick up Slightly in Longer Term NEW YORK—The Federal Reserve Bank of New York's Center for Microeconomic Data today released the December 2022 Survey of Consumer Expectations, which shows that inflation expectations continued to decline in the short term and were unchanged over the ...
| |||||||
Sesame Allergy Rule Leads to Unintended Consequences To help protect individuals with sesame allergies, the Food and Drug Administration (FDA) declared the seed a "major food allergen" on Jan. 1. But that may have led to some unintended consequences.. The declaration means food companies and ...
| |||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar